谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

Stephen T Oh,Moshe Talpaz,Aaron T Gerds,Vikas Gupta,Srdan Verstovsek,Ruben Mesa,Carole B Miller,Candido E Rivera,Angela G Fleischman,Swati Goel,Mark L Heaney,Casey O'Connell,Murat O Arcasoy,Yafeng Zhang,Jun Kawashima,Tomas Ganz,Mark Kowalski,Carrie Baker Brachmann

Blood Advances（2020）

引用 68|浏览71
暂无评分
关键词
acvr1/jak1/jak2 inhibitor momelotinib,myelofibrosis phase,transfusion dependency
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要